Use of tumor cell lysate to develop peptide vaccine targeting cancer-testis antigens

por Malhotra, Jyoti, Mehnert, Janice M.
Publicado 2021

Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma

por Xie, Xiaoqi, White, Eileen P., Mehnert, Janice M.
Publicado 2013

Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab

por Patel, Akshar N., Mehnert, Janice M., Kim, Sung
Publicado 2012

When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic Disease

por Spencer, Kristen R., Miettinen, Markku M., Maki, Robert G., Mehnert, Janice M.
Publicado 2013

Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors

por Gulati, Nicholas, Celen, Arda, Johannet, Paul, Mehnert, Janice M., Weber, Jeffrey, Krogsgaard, Michelle, Osman, Iman, Zhong, Judy
Publicado 2021

The Association of Radiation Therapy and Chemotherapy on Overall Survival in Merkel Cell Carcinoma: A Population-Based Analysis

por Vayntraub, Aleksander, Tayeb, Nadine, Squires, Bryan, Mehnert, Janice M, Hassan II, Quais, Sebastian, Nikhil T, Deryaniyagala, Rohan, Quinn, Thomas J
Publicado 2021

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

por Johannet, Paul, Liu, Wenke, Fenyo, David, Wind-Rotolo, Megan, Krogsgaard, Michelle, Mehnert, Janice M., Weber, Jeffrey S., Zhong, Judy, Osman, Iman
Publicado 2022

Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma

por Chesney, Jason, Puzanov, Igor, Collichio, Frances, Milhem, Mohammed M., Hauschild, Axel, Chen, Lisa, Sharma, Anjali, Garbe, Claus, Singh, Parminder, Mehnert, Janice M.
Publicado 2019

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

por Andtbacka, Robert H.I., Amatruda, Thomas, Nemunaitis, John, Zager, Jonathan S., Walker, John, Chesney, Jason A., Liu, Kate, Hsu, Cheng-Pang, Pickett, Cheryl A., Mehnert, Janice M.
Publicado 2019

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

por Kelly, Karen, Infante, Jeffrey R., Taylor, Matthew H., Patel, Manish R., Wong, Deborah J., Iannotti, Nicholas, Mehnert, Janice M., Loos, Anja H., Koch, Helga, Speit, Isabell, Gulley, James L.
Publicado 2018

Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series

por Ravi, Sowmya, Spencer, Kristen, Ruisi, Mary, Ibrahim, Nageatte, Luke, Jason J, Thompson, John A, Shirai, Keisuke, Lawson, David, Bartell, Heddy, Kudchadkar, Ragini, Gunter, Ngoc Thi, Mehnert, Janice M, Lipson, Evan J
Publicado 2014

Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer

por Wang, Shang-Jui, Khullar, Karishma, Kim, Sinae, Yegya-Raman, Nikhil, Malhotra, Jyoti, Groisberg, Roman, Crayton, Samuel H, Silk, Ann W, Nosher, John L, Gentile, Michael A, Mehnert, Janice M, Jabbour, Salma K
Publicado 2020

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

por Silk, Ann W., Curti, Brendan, Bryan, Jennifer, Saunders, Tracie, Shih, Weichung, Kane, Michael P., Hannon, Phoebe, Fountain, Christopher, Felcher, Jessica, Zloza, Andrew, Kaufman, Howard L., Mehnert, Janice M., McDermott, David F.
Publicado 2023

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

por Keilholz, Ulrich, Mehnert, Janice M., Bauer, Sebastian, Bourgeois, Hugues, Patel, Manish R., Gravenor, Donald, Nemunaitis, John J., Taylor, Matthew H., Wyrwicz, Lucjan, Lee, Keun-Wook, Kasturi, Vijay, Chin, Kevin, von Heydebreck, Anja, Gulley, James L.
Publicado 2019

A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

por Silk, Ann W., Saraiya, Biren, Groisberg, Roman, Chan, Nancy, Spencer, Kristen, Girda, Eugenia, Shih, Weichung, Palmeri, Marisa, Saunders, Tracie, Berman, Robert M., Coric, Vlad, Chen, Suzie, Zloza, Andrew, Vieth, Joshua, Mehnert, Janice M., Malhotra, Jyoti
Publicado 2022

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II tria...

por Chesney, Jason A, Puzanov, Igor, Collichio, Frances A, Singh, Parminder, Milhem, Mohammed M, Glaspy, John, Hamid, Omid, Ross, Merrick, Friedlander, Philip, Garbe, Claus, Logan, Theodore, Hauschild, Axel, Lebbé, Celeste, Joshi, Harshada, Snyder, Wendy, Mehnert, Janice M
Publicado 2023

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

por Silk, Ann W., Kaufman, Howard L., Curti, Brendan, Mehnert, Janice M., Margolin, Kim, McDermott, David, Clark, Joseph, Newman, Jenna, Bommareddy, Praveen K., Denzin, Lisa, Najmi, Saltanat, Haider, Azra, Shih, Weichung, Kane, Michael P., Zloza, Andrew
Publicado 2020

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

por Mehnert, Janice M., Varga, Andrea, Brose, Marcia S., Aggarwal, Rahul R., Lin, Chia-Chi, Prawira, Amy, de Braud, Filippo, Tamura, Kenji, Doi, Toshihiko, Piha-Paul, Sarina A., Gilbert, Jill, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D., Keam, Bhumsuk
Publicado 2019

The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021

por Ascierto, Paolo A., Warner, Allison Betof, Blank, Christian, Caracò, Corrado, Demaria, Sandra, Gershenwald, Jeffrey E., Khushalani, Nikhil I., Long, Georgina V., Luke, Jason J., Mehnert, Janice M., Robert, Caroline, Rutkowski, Piotr, Tawbi, Hussein A., Osman, Iman, Puzanov, Igor
Publicado 2022

Expanding access to early phase trials: the CATCH-UP.2020 experience

por Baranda, Joaquina C, Diaz, Francisco J, Rubinstein, Larry, Shields, Anthony F, Dayyani, Farshid, Mehta, Amitkumar, Mehnert, Janice M, Trent, Jonathan, Mabaera, Rodwell, Mooney, Margaret, Moscow, Jeffrey A, Doroshow, James, Waters, Brittany, Ivy, Percy, Gore, Steven D, Thomas, Alexandra
Publicado 2022